Target intelligence / Profile preview

Transcription factor E2F4 (E2F4)

Target
E2F4
Molecular classification
Transcription factor
01

Overview

Transcription factor E2F4 (E2F4) is a member of the E2F family of transcription factors, which are critical regulators of cell cycle progression, DNA repair, apoptosis, and differentiation. E2F4 primarily acts as a transcriptional repressor via interactions with the pocket proteins p130 (RBL2) and p107 (RBL1), forming complexes that inhibit expression of proliferation-associated genes, but can also function as an activator in certain contexts[1][2][4]. It plays a role in enforcing cell cycle arrest, particularly in quiescent cells, and can bind to both promoters and distal genomic regions, influencing expression of protein-coding genes and non-coding RNAs; aberrant expression or mutation of E2F4 has been linked to oncogenic processes and human cancers[1][3][2][4].

Other names
E2F4E2F-4p107/p130-binding proteinE2F transcription factor 4p107/p130-bindingE2F family member 4
02

Mechanism of action

Transcriptional repression via recruitment of pocket proteins (p130, p107, pRB); Formation of repressor complexes; Modulation of cell cycle and cell fate genes; Regulation of enhancer elements at distal genomic sites

03

Biological functions

Cell cycle regulationTranscriptional repressionTranscriptional activationDNA repairApoptosisCell differentiation
04

Disease associations

CancerOther (including developmental disorders)
05

Safety considerations

Potential effects on cell cycle arrest, proliferation, and tumor suppression; off-target modulation could disrupt normal tissue homeostasis or differentiation pathways
06

Biomarkers

E2F4 expression (as a prognostic biomarker in certain cancers, e.g., head and neck squamous cell carcinoma)

Beyond the preview

Go deeper on Transcription factor E2F4 (E2F4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor E2F4 (E2F4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call